December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immutep Limited - American Depositary Shares (NQ:IMMP)

3.130 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,751
Open 3.130
Bid (Size) 3.100 (1,900)
Ask (Size) 3.120 (700)
Prev. Close 3.130
Today's Range 3.130 - 3.130
52wk Range 1.320 - 3.530
Shares Outstanding 748,152,935
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
SurgePays (NASDAQ: SURG) Expands Growth Strategy – New Lead-Driver to Boost Fintech Revenue – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
What's going on in today's session ↗
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill

Performance

YTD
+41.6%
+41.6%
1 Month
+54.2%
+54.2%
3 Month
+74.9%
+74.9%
6 Month
+90.9%
+90.9%
1 Year
+50.5%
+50.5%

More News

Read More
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa
From Immutep Limited
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer
From Immutep Limited
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo ↗
Via Benzinga
News headline image
Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
From Immutep Limited
Via GlobeNewswire
News headline image
Unusual volume stocks in Wednesday's session ↗
Via Chartmill
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial ↗
Via Benzinga
News headline image
Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
From Immutep Limited
Via GlobeNewswire
News headline image
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September ↗
Via Benzinga
Topics Stocks
News headline image
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Via InvestorPlace
News headline image
Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars ↗
Via Benzinga
News headline image
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? ↗
Via Benzinga

Frequently Asked Questions

Is Immutep Limited - American Depositary Shares publicly traded?
Yes, Immutep Limited - American Depositary Shares is publicly traded.
What exchange does Immutep Limited - American Depositary Shares trade on?
Immutep Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Immutep Limited - American Depositary Shares?
The ticker symbol for Immutep Limited - American Depositary Shares is IMMP on the Nasdaq Stock Market
What is the current price of Immutep Limited - American Depositary Shares?
The current price of Immutep Limited - American Depositary Shares is 3.130
When was Immutep Limited - American Depositary Shares last traded?
The last trade of Immutep Limited - American Depositary Shares was at 12/26/25 04:00 PM ET
What is the market capitalization of Immutep Limited - American Depositary Shares?
The market capitalization of Immutep Limited - American Depositary Shares is 2.34B
How many shares of Immutep Limited - American Depositary Shares are outstanding?
Immutep Limited - American Depositary Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.